Biological E Archives - India Podcast https://indiapodcast.com/tag/biological-e/ Audio-Video-Text Tue, 09 Dec 2025 11:16:50 +0000 en-US hourly 1 https://wordpress.org/?v=7.1.3 https://indiapodcast.com/wp-content/uploads/2026/05/cropped-favicon-32x32.png Biological E Archives - India Podcast https://indiapodcast.com/tag/biological-e/ 32 32 Massive Investment Wave at Telangana Summit https://indiapodcast.com/telangana-global-summit-investments/ Tue, 09 Dec 2025 11:16:50 +0000 https://www.indiapodcast.com/?p=35964 Major investments continued on the second day of the Telangana Rising Global Summit in Bharat Future City. Chief Minister Revanth Reddy met several leading industrial groups and secured new MoUs. Companies announced commitments worth ₹1,04,350 crore for large-scale projects across key sectors. Godrej Jersey confirmed its plan to expand dairy operations with an investment of […]

The post Massive Investment Wave at Telangana Summit appeared first on India Podcast.

]]> Major investments continued on the second day of the Telangana Rising Global Summit in Bharat Future City. Chief Minister Revanth Reddy met several leading industrial groups and secured new MoUs. Companies announced commitments worth ₹1,04,350 crore for large-scale projects across key sectors.

Godrej Jersey confirmed its plan to expand dairy operations with an investment of ₹150 crore. The company requested 40 acres for the project and promised 300 direct jobs. Fortis India Pvt. Ltd. signed an MoU for a ₹2,000-crore Food and Agriculture R&D Centre and a rare-sugars manufacturing unit, creating over 800 direct jobs. Several FMCG and food manufacturers, including KJS India and Vintage Coffee, also committed more than ₹1,700 crore for new units.

Electronics and tech companies announced major commitments as well. Reliance Consumer Products will invest ₹1,500 crore in a multi-product FMCG unit. Kine’s Technology agreed to invest over ₹1,000 crore for electronics manufacturing. Additionally, large data-centre investments came from JCK Infra Projects (₹9,000 crore), Aquilon Nexus (₹6,750 crore), and InfraKey DC Parks (₹70,000 crore), promising thousands of skilled jobs.

Pharmaceutical companies announced strong interest in Telangana. Hetero Group will invest ₹1,800 crore and generate over 9,000 jobs. Bharat Biotech committed ₹1,000 crore for an advanced CRDMO facility. Aurobindo Pharma, Granules India, and Biological E will together invest over ₹7,200 crore in expansions focused on vaccines, biosimilars, peptides, and oncology manufacturing.

The post Massive Investment Wave at Telangana Summit appeared first on India Podcast.

]]> ICMR Develops Indigenous Malaria Vaccine AdFalciVax https://indiapodcast.com/adfalcivax-malaria-vaccine/ Wed, 10 Sep 2025 04:43:56 +0000 https://www.indiapodcast.com/?p=6914 The Indian Council of Medical Research (ICMR) has developed the country’s first indigenous malaria vaccine named AdFalciVax. This recombinant vaccine was created jointly by the Regional Medical Research Centre (RMRC) in Bhubaneswar, the National Institute of Malaria Research (NIMR), and the Department of Biotechnology’s National Institute of Immunology (DBT-NII). AdFalciVax specifically targets Plasmodium falciparum, the […]

The post ICMR Develops Indigenous Malaria Vaccine AdFalciVax appeared first on India Podcast.

]]> The Indian Council of Medical Research (ICMR) has developed the country’s first indigenous malaria vaccine named AdFalciVax. This recombinant vaccine was created jointly by the Regional Medical Research Centre (RMRC) in Bhubaneswar, the National Institute of Malaria Research (NIMR), and the Department of Biotechnology’s National Institute of Immunology (DBT-NII).

AdFalciVax specifically targets Plasmodium falciparum, the deadliest malaria parasite. It not only protects individuals from infection but also prevents transmission through mosquitoes, breaking the disease cycle. Health experts believe this vaccine could be a turning point in India’s fight against malaria.

Pre-clinical studies revealed strong immune responses and long-lasting protection. Unlike traditional vaccines, AdFalciVax offers broader coverage and remains stable at room temperature for up to nine months. This feature makes it easier to transport and store in remote areas where refrigeration is often unavailable.

The vaccine is produced using the safe bacterium Lactococcus lactis. For nationwide production, ICMR has licensed five companies: Indian Immunologicals Limited, TexInvention Lifecare, Panacea Biotech, Biological E Limited, and Zydus Lifesciences. The first batch is expected to be available by the end of this year, raising hopes for large-scale malaria control.

The post ICMR Develops Indigenous Malaria Vaccine AdFalciVax appeared first on India Podcast.

]]>